GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Tax Expense

Chordia Therapeutics (TSE:190A) Tax Expense : 円2.42 Mil (TTM As of Aug. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Tax Expense?

Chordia Therapeutics's tax expense for the months ended in Aug. 2024 was 円2.42 Mil. Its tax expense for the trailing twelve months (TTM) ended in Aug. 2024 was 円2.42 Mil.


Chordia Therapeutics Tax Expense Historical Data

The historical data trend for Chordia Therapeutics's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Tax Expense Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Tax Expense
1.90 2.42 2.42 2.42

Chordia Therapeutics Quarterly Data
Aug21 Aug22 Aug23 Aug24
Tax Expense 1.90 2.42 2.42 2.42

Chordia Therapeutics Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordia Therapeutics  (TSE:190A) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Chordia Therapeutics Tax Expense Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordia Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines